- Home
- IMNM vs EVER Comparison
IMNM vs EVER Comparison
Compare IMNM & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- EVER
- Stock Information
- Founded
- IMNM 2006
- EVER 2008
- Country
- IMNM United States
- EVER United States
- Employees
- IMNM N/A
- EVER N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- EVER Computer Software: Programming Data Processing
- Sector
- IMNM Health Care
- EVER Technology
- Exchange
- IMNM Nasdaq
- EVER Nasdaq
- Market Cap
- IMNM 987.1M
- EVER 929.6M
- IPO Year
- IMNM 2020
- EVER 2018
- Fundamental
- Price
- IMNM $13.83
- EVER $22.20
- Analyst Decision
- IMNM Strong Buy
- EVER Strong Buy
- Analyst Count
- IMNM 9
- EVER 5
- Target Price
- IMNM $24.89
- EVER $31.40
- AVG Volume (30 Days)
- IMNM 2.0M
- EVER 417.0K
- Earning Date
- IMNM 11-12-2025
- EVER 11-03-2025
- Dividend Yield
- IMNM N/A
- EVER N/A
- EPS Growth
- IMNM N/A
- EVER N/A
- EPS
- IMNM N/A
- EVER 1.24
- Revenue
- IMNM $12,589,000.00
- EVER $615,246,000.00
- Revenue This Year
- IMNM N/A
- EVER $32.27
- Revenue Next Year
- IMNM $154.70
- EVER $11.05
- P/E Ratio
- IMNM N/A
- EVER $17.84
- Revenue Growth
- IMNM 16.74
- EVER 92.92
- 52 Week Low
- IMNM $5.15
- EVER $16.63
- 52 Week High
- IMNM $15.13
- EVER $30.03
- Technical
- Relative Strength Index (RSI)
- IMNM 67.38
- EVER 37.56
- Support Level
- IMNM $11.25
- EVER $21.81
- Resistance Level
- IMNM $12.00
- EVER $22.73
- Average True Range (ATR)
- IMNM 1.01
- EVER 0.70
- MACD
- IMNM 0.40
- EVER -0.20
- Stochastic Oscillator
- IMNM 87.06
- EVER 12.47
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.